Comments
Loading...
Aprea Therapeutics (APRE) Forecast
NewsEarningsAprea Therapeutics (APRE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAprea Therapeutics (NASDAQ:APRE) Stock Quotes, Forecast and News Summary
Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aprea Therapeutics (APRE) stock?
You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.
Who are Aprea Therapeutics (APRE) competitors?
Other companies in Aprea Therapeutics’s space includes: Nanoviricides (AMEX:NNVC), Geovax Labs (NASDAQ:GOVX), Sensei Biotherapeutics (NASDAQ:SNSE), Indaptus Therapeutics (NASDAQ:INDP) and Tonix Pharmaceuticals (NASDAQ:TNXP).
What is the forecast, or price target, for Aprea Therapeutics (APRE) stock?
Aprea Therapeutics has a consensus price target of $10.60.
What is the current price for Aprea Therapeutics (APRE)?
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $3.35 last updated November 11, 2024 at 6:01 PM EST.
Does Aprea Therapeutics (APRE) pay a dividend?
There are no upcoming dividends for Aprea Therapeutics.
When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?
Aprea Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Aprea Therapeutics (APRE) going to split?
There is no upcoming split for Aprea Therapeutics.
What sector and industry does Aprea Therapeutics (APRE) operate in?
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.